Education
About Us
Working with TipRanks
Follow Us
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
Total Valuation
OncoSil Medical Ltd has a market cap or net worth of AU$11.52M. The enterprise value is -AU$8.36M.
Market CapAU$11.52M
Enterprise Value-AU$8.36M
Share Statistics
OncoSil Medical Ltd has 11,516,456 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,516,456
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OncoSil Medical Ltd’s return on equity (ROE) is -2.52 and return on invested capital (ROIC) is -249.30%.
Return on Equity (ROE)-2.52
Return on Assets (ROA)-1.77
Return on Invested Capital (ROIC)-249.30%
Return on Capital Employed (ROCE)-2.51
Revenue Per Employee258.32K
Profits Per Employee-5.96M
Employee Count2
Asset Turnover0.08
Inventory Turnover12.39
Valuation Ratios
The current PE Ratio of OncoSil Medical Ltd is -0.93. OncoSil Medical Ltd’s PEG ratio is -0.04.
PE Ratio-0.93
PS Ratio0.00
PB Ratio1.38
Price to Fair Value2.34
Price to FCF>-0.01
Price to Operating Cash Flow-0.94
PEG Ratio-0.04
Income Statement
In the last 12 months, OncoSil Medical Ltd had revenue of 516.63K and earned -11.91M in profits. Earnings per share was -0.01.
Revenue516.63K
Gross Profit-993.12K
Operating Income-11.98M
Pretax Income-11.91M
Net Income-11.91M
EBITDA-11.98M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -12.63M and capital expenditures -208.41K, giving a free cash flow of -12.84M billion.
Operating Cash Flow-12.63M
Free Cash Flow-12.84M
Free Cash Flow per Share-1.11
Dividends & Yields
OncoSil Medical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change-77.73%
50-Day Moving Average4.77
200-Day Moving Average―
Relative Strength Index (RSI)19.22
Average Volume (3m)17.80K
Important Dates
OncoSil Medical Ltd upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
OncoSil Medical Ltd as a current ratio of 3.26, with Debt / Equity ratio of 0.83%
Current Ratio3.26
Quick Ratio3.19
Debt to Market Cap0.00
Net Debt to EBITDA0.37
Interest Coverage Ratio-3.04K
Taxes
In the past 12 months, OncoSil Medical Ltd has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
OncoSil Medical Ltd EV to EBITDA ratio is -0.56, with an EV/FCF ratio of -0.60.
EV to Sales12.90
EV to EBITDA-0.56
EV to Free Cash Flow-0.60
EV to Operating Cash Flow-0.62
Balance Sheet
OncoSil Medical Ltd has AU$8.47M in cash and marketable securities with AU$70.84K in debt, giving a net cash position of -AU$8.40M billion.
Cash & Marketable SecuritiesAU$8.47M
Total DebtAU$70.84K
Net Cash-AU$8.40M
Net Cash Per Share-AU$0.73
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is -170.79%, with operating margin of -2319.68%, and net profit margin of -2306.02%.
Gross Margin-170.79%
Operating Margin-2319.68%
Pretax Margin-2306.02%
Net Profit Margin-2306.02%
EBITDA Margin-2318.12%
EBIT Margin-2305.91%
Analyst Forecast
The average price target for OncoSil Medical Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast271.05%
EPS Growth Forecast42.55%